Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Osteonecroses in Pediatric Patients With ALL (OPAL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Heinrich-Heine University, Duesseldorf
Sponsor:
Information provided by (Responsible Party):
Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu, Heinrich-Heine University, Duesseldorf
ClinicalTrials.gov Identifier:
NCT01619124
First received: June 6, 2012
Last updated: March 4, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2020
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)